M&A Deal Summary

Ikonisys Acquires Hospitex

On November 23, 2023, Ikonisys acquired medical products company Hospitex for 5M EUR

Acquisition Highlights
  • This is Ikonisys’ 1st transaction in the Medical Products sector.
  • This is Ikonisys’ largest (disclosed) transaction.
  • This is Ikonisys’ 1st transaction in France.

M&A Deal Summary
Date 2023-11-23
Target Hospitex
Sector Medical Products
Buyer(s) Ikonisys
Deal Type Add-on Acquisition
Deal Value 5M EUR

Target

Hospitex

Florence, France
Hospitex is a Thin Layer Cytology and Cancer Diagnostics company that provides laboratory instrumentations in cytology and has developed a unique patented platform for slide preparation called Nephelometric Smart Technology (NST). It provides advanced solutions for very accurate standardized single-layer liquid-based cytology (LBC) slides. This cutting-edge technology enables the company to produce thin-layer diagnostic slides for any organ targeted. Hospitex is based in Florence, France.

Search 199,096 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ikonisys

Parigi, France
Category Company
Founded 1999
Sector Life Science
DESCRIPTION

Ikonisys is a cell-based diagnostics company specializing in the early and accurate detection of cancer. The company develops, produces, and markets the proprietary Ikoniscope20 and Ikoniscope20max platforms, fully automated solutions designed to deliver accurate and reliable detection and analysis of rare and very rare cells. Ikonisys was formed in 1999 and is based in Parigi, France.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (France) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal